LYNNTECH INC. — Department of Defense SBIR Phase II: SOCOM16-002

Description

A shared objective in Combat Casualty Care and in Prolonged Field care is to overcome the different challenges posed by conducting of operations under austere conditions. This can be achieved in part by providing capable and functional diagnostic and treatment methods for use at the point of injury. The research described in this proposal addresses the urgent need for an improved blood analysis system for casualty monitoring in far forward field care situations, motivated by the fact that real time blood analysis is central to the effective diagnosis and treatment of the most common combat injuries. In Phase I, Lynntech performed a thorough feasibility study and developed a suite of electronic and optical measures for blood analytes relevant to trauma, transfusion, and other traditionally Role 3 functions, towards a simple device for use in Role 1 or 2. The components of the blood analyzer are unaffected by harsh environmental conditions, addressing a debilitating limitation of the current technology. The Phase II effort aims to integrate the various innovations from Phase I, followed by prototype development and extensive testing and evaluation, towards a comprehensive blood analysis suite that meets or exceeds the requirements set forth by the US SOCOM.